文献速递生殖医学

全基因组差异甲基化分析鉴定男性不育的甲基化特征

Genome-wide differential methylation analyses identifies methylation signatures of male infertility.
PubMed 文献 · Hum Reprod · 2018-01-01

这项病例对照研究对38例少精/少弱精不育患者和26例精液正常fertile男性的精子DNA做全基因组甲基化分析,发现1680个差异甲基化CpG位点,分布于1052个基因,涉及印记基因、精子发生相关基因及甲基化调控基因等;深度测序验证了HOXB1、GATA3、EBF3、BCAN和TCERG1L等候选基因。

要点

  • 共鉴定1680个差异甲基化CpG位点,其中1436个高甲基化、244个低甲基化。
  • 差异甲基化涉及BCAN、CTNNA3、GATA3、MAGI2、TP73等印记基因及SPATA系列精子发生相关基因。
  • HOXB1、GATA3、EBF3、BCAN和TCERG1L经深度测序验证,是进一步研究的有力候选基因。

核心结论

  • 精子DNA甲基化改变与生精障碍及不育相关,共涉及1052个基因上的1680个差异甲基化CpG位点。
  • 作者认为差异甲基化CpG位点可作为不育筛查组合的标志物,尤其是与既往研究一致的差异甲基化基因。
  • 作者认为经深度测序验证的基因是研究其在精子发生中作用的有力候选。

研究设计与样本

  • 病例对照研究,使用38例少精/少弱精不育患者和26例精液正常fertile男性的精子DNA。
  • 采用450K BeadChip对6例不育男性和6例fertile男性的精子DNA做全基因组甲基化分析以识别差异甲基化CpG位点。
  • 随后对32例不育患者和20例fertile对照的精子DNA进行深度测序。

主要发现

  • 共鉴定1680个差异甲基化CpG位点,其中1436个高甲基化、244个低甲基化。
  • 差异甲基化基因包括印记基因BCAN、CTNNA3、DLGAP2、GATA3、MAGI2和TP73。
  • 精子发生相关基因包括SPATA5、SPATA7、SPATA16和SPATA22;甲基化及基因表达调控基因包括KDM4C、JMJD1C、EZH2和HDAC4。
  • 补体与免疫应答相关基因包括HLA-C、HLA-DRB6和HLA-DQA1;其他基因包括CRISPLD1、LPHN3和CPEB2。
  • 深度测序显示HOXB1、GATA3、EBF3、BCAN和TCERG1L存在显著差异甲基化,为后续研究的有力候选基因,并通过select基因深度测序排除了偶然性。

临床怎么用

  • 作者认为差异甲基化CpG位点可纳入不育筛查组合作为标志物,尤其是与既往研究一致的差异甲基化基因。
  • 作者认为经深度测序验证的基因是研究其在精子发生中作用的有力候选。

局限性

  • 全基因组分析相当准确,但可能无法在重复研究中对所有差异甲基化CpG位点得到完全验证。
  • 全基因组甲基化分析使用了t检验,其他检验可能提供更稳健、更有力的分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do methylation changes in sperm DNA correlate with infertility? STUDY ANSWER: Loss of spermatogenesis and fertility was correlated with 1680 differentially-methylated CpGs (DMCs) across 1052 genes. WHAT IS KNOWN ALREADY: Methylation changes in a number of genes have been correlated with reduced sperm count and motility. STUDY DESIGN, SIZE, DURATION: This case-control study used spermatozoal DNA from 38 oligo-/oligoastheno-zoospermic infertile patients and 26 normozoospermic fertile men. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: Genome-wide methylation analysis was undertaken using 450 K BeadChip on spermatozoal DNA from six infertile and six fertile men to identify DMCs. This was followed by deep sequencing of spermatozoal DNA from 32 infertile patients and 20 fertile controls. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 1680 DMCs were identified, out of which 1436 were hypermethylated and 244 were hypomethylated. Classification of DMCs according to the genes identified BCAN, CTNNA3, DLGAP2, GATA3, MAGI2 and TP73 among imprinted genes, SPATA5, SPATA7, SPATA16 and SPATA22 among spermatogenesis-associated genes, KDM4C and JMJD1C, EZH2 and HDAC4 among genes which regulate methylation and gene expression, HLA-C, HLA-DRB6 and HLA-DQA1 among complementation and immune response genes, and CRISPLD1, LPHN3 and CPEB2 among other genes. Genes showing significant differential methylation in deep sequencing, i.e. HOXB1, GATA3, EBF3, BCAN and TCERG1L, are strong candidates for further investigations. The role of chance was ruled out by deep sequencing of select genes. LARGE-SCALE DATA: N/A. LIMITATIONS, REASON FOR CAUTION: Genome-wide analyses are fairly accurate, but may not be exactly validated in replication studies across all DMCs. We used the 't' test in the genome-wide methylation analysis, whereas other tests could provide a more robust and powerful analysis. WIDER IMPLICATIONS OF THE FINDINGS: DMCs can serve as markers for inclusion in infertility screening panels, particularly those in the genes showing differential methylation consistent with previous studies. The genes validated by deep sequencing are strong candidates for investigations of their roles in spermatogenesis. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the Council of Scientific and Industrial Research (CSIR), Govt. of India with grant number BSC0101 awarded to Rajender Singh. None of the authors has any competing interest to declare.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Sujit KM, Sarkar S, Singh V, et al. Genome-wide differential methylation analyses identifies methylation signatures of male infertility. Hum Reprod. 2018. PMID: 30358834. doi:10.1093/humrep/dey319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。